dsip proposal number is Now LIVE - Accepting Phase II Proposals sbir #sttr #dowinnovates #smallbusiness #innovation

DoD Directive 5220.22, DoD Industrial Security Program, 8 December 1980

GLP-1 receptor agonist inhibited proinflammatory monocyte chemoattractant protein-1 secretion from human atherosclerotic plaque samples and monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor- (TNF-), and interleukin (IL)-1 secretion from human macrophages after ex vivo treatment

doi:10.3109/10715762.2011.597750 Ambrogini P, Minelli A, Galati C, et al

The primary benefits of tirzepatideimproved glucose management and weight reductionremain the therapeutic focus, with creatine serving as an adjunct to support body composition goals when clinically appropriate